MigraineMind research summary

Delayed Access Is a Migraine Risk Factor: Precision Triage as the Missing Link in Modern Headache Care.

Cureus | 2026

Editorial / commentary
AuthorsSkudar S
JournalCureus
Publication year2026
PubMed ID42422641

Summary

Migraine care has advanced in precision, yet many patient pathways remain confusing. Many patients face delays in diagnosis and experience underestimated disability. This leads to increased acute medication use. Delayed access is not just an administrative issue; it is a modifiable risk factor. This risk factor may lead to migraine progression and increased disability. The paper suggests using precision triage as a solution. This involves linking headache classification with burden assessment and medication-overuse risk. It emphasizes timely referrals and effective use of digital health tools. A shift is necessary from disconnected visits to a pathway-based model. This model focuses on identifying patient needs and urgency. Such changes could help translate existing knowledge into more effective migraine care. Ultimately, better care could lead to quicker, fairer treatment options for patients. Improving the system could reduce suffering and enhance quality of life for many people. Clinical relevance: This research highlights the importance of timely access to migraine care to improve patient outcomes and reduce disability.

Key Learning Points

  • Many patients experience delays in migraine diagnosis, which can lead to increased use of acute medications and greater disability.
  • Timely access to migraine care is crucial for improving patient outcomes and reducing suffering.
  • Using precision triage can help link headache classification with the assessment of burden and medication-overuse risk.
  • A shift to a pathway-based model can better address patient needs and urgency in migraine care.
  • Improving the migraine care system can enhance patients' quality of life and provide quicker, fairer treatment options.

Original research

Read the original publication and review its full methods and findings on PubMed.

MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.